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Jablonski, Kristen Lynn (Ph.D., Integrative Physiology) 
Dietary Sodium Restriction and Vascular Dysfunction with Aging 
Thesis directed by Professor Douglas R. Seals 
 
Endothelial dysfunction, commonly assessed as a decline in endothelium-dependent 
dilation (EDD), is a clinically important predictor of future cardiovascular diseases (CVD).  EDD 
is reduced with age and elevated systolic blood pressure (SBP), whether assessed as brachial 
artery flow-mediated dilation (FMDBA) or as the forearm blood flow response to acetylcholine 
(FBFACh).  Thus, establishing the efficacy of interventions that may preserve EDD in this 
population is a high biomedical research priority.  Dietary sodium restriction (DSR) is one 
potential intervention.  While the influence of sodium on BP is widely documented and 
appreciated, high dietary sodium has other adverse effects on cardiovascular health, 
independent of its effect on BP.  Accordingly, the purpose of these studies was to determine a) 
if reduced sodium intake is associated with enhanced EDD in middle-aged and older adults 
(MA/O) with moderately elevated SBP; b) if DSR improves EDD in this group; and c) the 
physiological mechanisms mediating any improvements.  
In cross-sectional analyses, FMDBA was 52% higher in subjects self-reporting low sodium 
intake (73±6 mmol/d), without differences in endothelium-independent dilation (EID), SBP or 
other subject characteristics.  In the entire cohort, FMD BA was inversely related to dietary 
sodium intake (%∆ r=-0.53, p<0.01).     
In the intervention study, EDD was 71% (FMDBA) and 53% (peak FBFACh) higher 
following 4 weeks of low sodium (70+8 mmol/day) vs. normal sodium (153+7 mmol/day) intake 
(p<0.05; randomized cross-over design), whereas EID did not change.  The improvements in 
EDD remained significant when correcting for SBP, and other subject characteristics/dietary 
factors did not change.  Functional improvements were mediated by increased nitric oxide (NO) 
bioavailability (significant reduction in FBFACh  with co-infusion of an endothelial nitric oxide 
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synthase inhibitor), increased tetrahydrobiopterin (BH4) bioavailability (FMDBA no longer 
improved with oral BH4) and reduced oxidative stress (FMDBA and FBFACh no longer improved 
with ascorbic acid infusion; reduced endothelial cell nitrotyrosine abundance). 
In conclusion, DSR reverses endothelial dysfunction in MA/O with moderately elevated 
SBP by enhancing NO and BH4 bioavailability and reducing oxidative stress. Thus, the 
physiological mechanisms modulating benefits of DSR are beyond BP lowering alone, and the 
potential impact of DSR upon CVD risk may be even greater than previously appreciated.  
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CHAPTER II 
 
Introduction  
 
Cardiovascular diseases (CVD) remain the leading cause of mortality in modern 
societies.  Importantly, as much as 80% of all CVD are associated with dysfunction and 
disorders of arteries (107).  Advancing age is a/the major risk factor for CVD (73).  Thus, aging 
adversely affects arteries, which increases risk of developing CVD (74).  One of the major 
contributors to the increased risk of CVD with aging is vascular endothelial dysfunction, most 
commonly assessed in humans as endothelium-dependent dilation (EDD) of a) peripheral 
conduit arteries in response to a mechanical (shear) stress (i.e. brachial artery flow-mediated 
dilation; FMDBA) or b) resistance vessels in response to a chemical stimulus (i.e. forearm blood 
flow to acetylcholine; FBFACh).  Both measures of EDD are clinically important predictors of 
future CVD and/or CV events (13, 63, 130). 
 Systolic blood pressure (SBP) increases progressively with age, whereas diastolic BP 
increases until ~age 50 and then levels off or even declines at older ages (74).  The increase in 
SBP with aging is associated with a marked increase in the prevalence of systolic essential 
hypertension (SBP>140 mmHg) (74).  50% of adults >60 years of age and 75% of adults >70 
years of age have essential hypertension, and this is primarily the result of systolic hypertension 
(24).  Middle-aged and older (MA/O) adults with elevated SBP have a greater risk of CVD 
compared with their non-hypertensive peers (120).  Thus, elevated SBP/systolic hypertension is 
the primary BP-related risk factor for adults >50 years of age.  The combined effect of age and 
elevated SBP on CVD risk is of particular importance for the present analyses, which sought to 
establish the efficacy of treatment of vascular endothelial dysfunction in this setting.     
 Dietary sodium restriction (DSR) is a lifestyle intervention that may improve vascular 
endothelial function in MA/O adults with elevated SBP.  Blood pressure sensitivity to sodium 
5 
 
intake (“salt sensitivity”) increases with age (129, 138) and is present in >50% of patients with 
hypertension (129).  Indeed, excess sodium intake is considered a causal factor in the 
development of systolic hypertension with aging (24).  High sodium intake also is associated 
with greater increases in aortic pulse-wave velocity (aPWV) with aging (5), and DSR reduces 
large elastic artery stiffness and improves carotid artery compliance in MA/O adults with 
elevated baseline SBP (59, 114).  In addition to large elastic artery stiffness, excessive sodium 
intake causes vascular endothelial dysfunction in peripheral arteries of experimental animals 
and humans (11, 123, 141).  However, it is unknown if low dietary sodium modulates vascular 
endothelial function in MA/O adults with moderately elevated SBP.   
In Chapter IV, I tested the hypothesis that dietary sodium intake is related to EDD in 
MA/O adults with moderately elevated SBP.  This study established that subjects reporting 
lower dietary sodium intake have greater EDD than their age-matched peers consuming a more 
typical American diet.  However, the study design could only identify an association and could 
not determine cause-and-effect.   
To test the efficacy of DSR for improving vascular endothelial function in this population, 
I performed a randomized, placebo-controlled, cross-over intervention.  In Chapter V, I tested 
the hypothesis that a low sodium diet (~50 mmol/day) would improve EDD compared to a 
“normal” (i.e. typical American) sodium diet (~150 mmol/day).  Subjects were placed on a low 
sodium diet for 10 weeks, and sodium was added-back during one half of the 10-week period 
using slow-release sodium tablets in a randomized, placebo-controlled design.    
 In humans, impaired EDD with aging is mediated primarily by reduced nitric oxide (NO) 
bioavailability, as indicated by the absence of age group differences when NO production by 
endothelial nitric oxide synthase (eNOS) is inhibited (118).  The reductions in NO bioavailability 
are, in turn, mediated by oxidative stress, as indicated by improvement or restoration of EDD 
with acute infusion of supra-physiological concentrations of the antioxidant, ascorbic acid 
(vitamin C) (51, 118).  Oxidative stress reduces NO bioavailability via excessive production of 
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reactive oxygen species, including superoxide, which reacts with NO to form peroxynitrite.  
Peroxynitrite, in turn: a) causes nitration of tyrosine residues on amino acids of proteins 
(nitrotyrosine), providing a useful cellular marker of oxidative stress (78, 105); and b) oxidizes 
tetrahydrobiopterin (BH4), an essential cofactor for NO synthesis by eNOS, converting BH4 to its 
inactive form, BH2.  The consequent reduction in bioavailability of BH4 leads to the “uncoupling” 
of eNOS, which produces more superoxide and less NO in a vicious cycle that further reduces 
NO bioavailability (16, 61, 75).   
 There is much less information as to how excessive sodium intake causes impaired 
EDD, especially in humans.  However, as with aging, the available data from rodents support 
the idea that sodium suppresses EDD by reducing NO bioavailability as the result of oxidative 
stress (97, 140, 141), possibly via oxidation and reduced bioavailability of BH4 (98).  Thus, in 
Chapter V, I also tested the hypothesis that the improvements in EDD with DSR are mediated 
by increased NO bioavailability, increased BH4 bioavailability and reduced oxidative stress.     
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Specific Aims 
 
Specific Aim 1 (Chapter IV): To determine if reduced sodium intake is associated with 
enhanced EDD in MA/O adults with moderately elevated SBP  
 
Specific Aim 2 (Chapter V): To determine if DSR improves EDD in MA/O adults with 
moderately elevated SBP 
 
Specific Aim 3 (Chapter V): To determine if the improvements in vascular endothelial function 
with DSR are mediated by NO and BH4 bioavailability, and reduced oxidative stress 
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CHAPTER III 
Portions of this chapter were published previously in Clin Sci (Lond) 120:357-75, 2011  
(DR Seals, KL Jablonski and AJ Donato) 
 
Review of Literature 
 
Endothelium-Dependent Dilation  
 
 Clinical Significance.  Despite reductions in death rates from cardiovascular diseases 
(CVD) over the last 4 decades, CVD remain the leading cause of morbidity and mortality in 
modern societies.  What is less appreciated, perhaps, is that the great majority of CVD (as 
much as 80%) are associated with dysfunction and disorders of arteries (85).  The vascular 
endothelium is a critical site for development of future CVD (13, 27, 130).  The endothelium is a 
single layer of cells lining the lumen of the vessel wall that interfaces with the blood.  Once 
believed to be merely a structural filter for the passage of molecules between the circulation and 
vascular wall, it is now known that the vascular endothelium secretes a variety of biologically 
active compounds that regulate the function and health of arteries.  Vascular endothelial 
dysfunction is viewed as a key antecedent of clinical arterial diseases and serves as a marker of 
the inherent risk of developing future CVD (62, 130).  Given its central role in the development 
of clinical coronary, cerebrovascular and peripheral artery diseases, vascular endothelial 
dysfunction is considered an important therapeutic target for reducing the risk of CVD morbidity 
and mortality (26, 130). 
 
 EDD and Aging.  Impaired endothelium-dependent dilation (EDD) is the central feature 
of vascular endothelial dysfunction and is an independent predictor of future clinical 
atherosclerotic disease and related events (13, 63, 130).  In the absence of clinical disease, 
healthy aging is associated with impaired conduit artery and microvascular EDD (22, 44, 51, 
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120).  In addition, systolic blood pressure (SBP) increases progressively with age, and the age-
associated impairments in EDD are exacerbated by the presence of systolic hypertension (37, 
113, 119).  The combined effect of age and elevated SBP on CVD risk is of particular 
importance for the present work, which sought to establish the efficacy of treatment of vascular 
endothelial dysfunction in this setting. 
Measurement of EDD in Humans.  Although coronary EDD has been assessed in 
patients with heart disease and in subjects undergoing diagnosis for coronary disease (29, 86, 
137), in general, EDD of peripheral arteries has been used to assess vascular endothelial 
function in humans (13, 34).  There are limited data suggesting that peripheral EDD correlates 
with EDD measured in the coronary arteries (2, 121) and, thus, may reflect disease processes 
in the coronary circulation.  Peripheral artery EDD is assessed by two primary methods: forearm 
blood flow (FBF) response to endothelium-dependent dilators and flow-mediated dilation (FMD).  
The FBF technique uses a chemical stimulus to evoke EDD (58).  A pharmacological 
agonist for nitric oxide (NO) synthesis and release from the vascular endothelium (most often 
acetylcholine (ACh)) is infused into an artery of a limb (usually the brachial artery) and the 
consequent increase blood flow to the distal portion of the limb (usually the forearm) is 
measured using venous occlusion plethysmography (70, 131).  A dose-response relation is 
established and group- or condition-differences are identified either by the slopes of the dose-
response curves or the peak blood flows attained.  The increase in blood flow reflects the 
dilation occurring in the resistance vessels (arterioles) of the distal limb.  Thus, this technique 
measures EDD of peripheral resistance vessels in response to a chemical stimulus.  The 
advantage of this methodology is that it allows for “pharmaco-dissection” of physiological 
mechanisms, such as the role of NO by inhibiting endothelial nitric oxide synthase (eNOS) with 
NG-monomethyl-L-arginine (L-NMMA). 
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The other method, FMD, uses a mechanical stimulus to evoke an EDD (60).  This 
approach involves inflating a cuff on a limb (typically the upper forearm) to a supra-systolic 
external pressure for several minutes and measuring the dilation in a segment of an artery 
(typically the brachial artery) proximal to the occlusion in response to the acute increase in 
blood flow produced by rapid deflation of the cuff (21).  The ischemia-evoked dilation of 
resistance vessels distal to the occlusion produces a marked temporary increase in blood flow 
(“hyperemic stimulus”) in the proximal conduit arteries that, in turn, causes a “flow-mediated 
dilation” (FMD) of those arteries.  Thus, this procedure assesses the ability of peripheral conduit 
arteries to dilate in response to the physiological stimulus of an acute increase in intravascular 
shear produced by an increase in blood flow (71).  Unlike the FBF technique that assesses EDD 
of resistance vessels, FMD assesses EDD of conduit arteries.  
Experiments performed in animals have established that the responses evoked by both 
approaches are “endothelium-dependent” because they are abolished after removal of the 
vascular endothelium (58, 104).  Moreover, the responses are primarily (although not 
completely) mediated by vascular endothelial production and release of NO because they are 
markedly attenuated by administration of agents that inhibit NO synthesis by eNOS, such as L-
NMMA (83, 96). 
In both experimental approaches, the possibility that group or condition differences 
observed are due to other (i.e., “endothelium-independent”) mechanisms can be assessed by 
determining the vasodilatory responses to intra-arterial infusion of sodium nitroprusside (i.a. 
infusion model) or sublingual administration of nitroglycerin (FMD model).  These drugs serve 
as “NO donors”, thus providing a measure of the sensitivity of the vascular smooth muscle cells 
in the arterial wall to NO (94, 104).  An absence of group or condition differences in response to 
endothelium-independent stimuli in the presence of clear differences in endothelium-dependent 
responses are interpreted as indicative of vascular endothelium-specific dysfunction in 
vasodilatory responsiveness. 
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Mechanisms of Impaired EDD with Aging.  Both animal and human data support that 
physiological mechanisms contributing to the age-associated reduction in EDD include reduced 
NO bioavailability, reduced tetrahydrobiopterin (BH4) bioactivity and increased oxidative stress 
(113).  The reduction in bioavailable NO with aging is supported by the fact that the reduction in 
EDD induced by pharmacological inhibition of NO production by eNOS is smaller with 
advancing age, with age group differences in EDD no longer existing in the absence of NO 
synthesis by eNOS (47, 81, 96).  This may be the result of either decreased stimulus-evoked 
NO production, increased NO removal, or both.     
Despite consistent observations of reduced NO bioavailability, analysis of arterial tissue 
in experimental animals indicates decreased, increased and unchanged eNOS expression 
and/or activation (i.e., phosphorylation at serine 1177) with aging (23, 47, 106, 127).  In healthy 
humans, eNOS protein expression tends to be greater in vascular endothelial cells obtained 
from the brachial artery of older compared with young adults (46), whereas eNOS 
phosphorylated at serine 1177 is significantly increased, suggesting a greater state of activation 
of the enzyme with aging (46).  If so, such activation with age in healthy adults may represent 
an attempt to compensate for low NO bioavailability.   
Tetrahydrobiopterin (BH4) is an essential co-factor for NO synthesis by eNOS (111).  
When bioavailability of BH4 is inadequate, eNOS becomes “uncoupled”, resulting in increased 
synthesis of the superoxide anion instead of NO (28, 75, 128).  Administration of BH4 to young 
and older humans causes a selective improvement in EDD in older adults (52, 66), which is 
abolished by L-NMMA (66). This suggests that the improvements are mediated by augmented 
NO bioavailability.  The mechanism responsible for the reduction in BH4 bioactivity with aging is 
unclear.  In rodents, BH4 concentrations in arteries have been reported to be either reduced (35, 
116) or unchanged (9) with aging.  However, consistent with observations in humans, 
augmenting vascular BH4 bioavailability in skeletal muscle arterioles of old rats restores NO-
mediated flow-induced dilation (35). 
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The available evidence suggests that the development of oxidative stress also 
contributes to vascular endothelial function with aging.  Nitration of tyrosine residues on proteins 
(nitrotyrosine) can be taken as a maker of oxidant damage, and nitrotyrosine increases in 
endothelial cells of humans (45) and arterioles from rodents (30, 47, 81, 106).  In healthy adults 
varying in age, brachial artery FMD is inversely related to circulating markers of oxidative stress 
(49, 53), as well as to nitrotyrosine staining in vascular endothelial cells (45).  An acute 
reduction in oxidative stress via infusion of antioxidants such as ascorbic acid selectively 
improves or restores EDD in older adults (51, 118). 
 The mechanisms contributing to arterial oxidative stress-associated vascular endothelial 
dysfunction with aging appear to involve increased production of reactive oxygen species in the 
face of unchanged or reduced antioxidant defenses.  Superoxide and other free radical 
bioactivity are increased with aging in skeletal muscle of humans (6) and in arteries of rodents 
(18, 64, 106).  Antioxidant enzyme expression in vascular endothelial cells is not different in 
young and older healthy adults (45), whereas expression and activity of these enzymes 
generally are unchanged or reduced in arteries of experimental animals (36, 47, 106, 132).  
That superoxide dismutase mimetics restore EDD in arteries of old rodents (81, 106, 122) 
supports a key role for increased superoxide in age-associated vascular endothelial dysfunction.   
 The sources of superoxide mediating impaired EDD with aging include upregulation of 
the oxidant enzyme nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase, 
uncoupling of eNOS and increased mitochondrial production (45, 47, 126, 134).  In contrast, the 
available evidence does not support a role for the oxidant enzymes xanthine oxidase or 
cytochrome P-450 epoxygenase2C9, at least in humans (44, 49).  Increased superoxide could 
reduce NO bioavailability and impair EDD with aging by reacting with NO to form peroxynitrite.  
In turn, peroxynitrite oxidizes BH4 to its inactive form, which both reduces NO production and 
increases superoxide production by eNOS (75).   
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Dietary Sodium  
 
 Clinical Significance.  Perhaps the most widely documented and appreciated influence 
of dietary sodium intake in humans is upon blood pressure, particularly SBP.  Blood pressure 
sensitivity to sodium intake (“salt sensitivity”) increases with age (129, 138) and is present in 
>50% of patients with hypertension (129).  Indeed, excess sodium intake is considered a causal 
factor in the development of systolic hypertension with aging (24), whereas evidence across 
various cultures supports that low dietary sodium intake slows the age-associated rise in blood 
pressure (91).  Restricting dietary sodium intake has been repeatedly demonstrated to lower 
blood pressure, particularly SBP (31, 65, 87, 109).  However, as discussed below, dietary 
sodium exerts cardiovascular effects beyond influencing blood pressure alone.      
 Lifestyle modifications remain the initial strategy for the prevention of age-associated 
CVD (24, 55, 112).  Dietary sodium restriction (DSR) is one such modification with enormous 
potential.  New evidence indicates that DSR may be an even more effective intervention for 
prevention of CVD and CV events than previously recognized (3, 8, 54, 117).  These data 
project that even modest reductions in sodium intake could reduce the number of new cases of 
coronary heart disease by 60,000 to 120,000 per year and, over the lifetime of adults aged 40-
85, avert 500,000 strokes and 480,000 myocardial infarctions, while increasing quality adjusted 
life-years by 2.1 million.  The CV benefits of DSR would be equivalent to or greater than those 
previously established for reductions in tobacco use, obesity and cholesterol.  
Dietary sodium restriction is a promising lifestyle modification for preventing CVD.  As 
recently stressed by the American Heart Association, the projected health and societal benefits 
resulting from population-wide dietary sodium restriction are substantial (8).  To date, such 
projections have focused on the effects of sodium restriction on blood pressure.  However, 
independent of its effects on blood pressure, high dietary sodium contributes to other adverse 
cardiovascular outcomes (39, 57, 110).  If DSR improves vascular endothelial function via 
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physiological mechanisms other than blood pressure lowering alone, the potential impact of 
reducing dietary sodium consumption upon risk of CVD may be even greater than presently 
appreciated.    
  Dietary Sodium and Vascular Function.  High sodium intake also is associated with 
greater increases in aortic pulse-wave velocity (a measure of arterial stiffness) with aging (5).  
Two previous intervention studies performed in the Seals laboratory have shown that dietary 
sodium restriction (50-60% reductions from baseline sodium intake to 50-60 mmol/d) reduces 
large elastic artery stiffness/increases compliance in MA/O adults with elevated baseline SBP, 
in the absence of changes in body mass or composition, metabolic risk factors or other dietary 
factors (59, 114).  In addition to large elastic artery stiffness, excessive sodium intake also 
causes vascular endothelial dysfunction in peripheral arteries of experimental animals and 
humans (11, 39, 123, 141).  Individuals with salt sensitive hypertension demonstrate decreased 
EDD compared to those with salt resistant hypertension, suggesting a causal role of sodium in 
endothelial dysfunction (15, 77, 92).  Thus, reducing sodium intake in MA/O adults with elevated 
baseline SBP may improve EDD, consistent with observations of increased FMD in 
overweight/obese adults following sodium restriction (40).  
 Mechanisms Linking Dietary Sodium and Vascular Function.  The adverse influence 
of high dietary sodium on arterial function is at least in part independent of blood pressure (57, 
115, 136).  In the most recent DSR intervention study published from the Seals laboratory, the 
improvements in vascular function remained significant after correcting for reductions in blood 
pressure using the beta-stiffness index expression of arterial compliance (59).  Other evidence 
in animals and humans also indicates that dietary sodium exerts cardiovascular effects beyond 
traditionally appreciated influences on blood pressure.  Negative consequences of high dietary 
sodium include left ventricular hypertrophy, fibrosis of the heart, kidney and arteries, functional 
and other structural changes to target organs, and increased oxidative stress (4, 56, 91).  
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Rodents resistant to changes in blood pressure in response to increased dietary sodium 
nevertheless develop vascular endothelial dysfunction (12, 80, 97, 139), and acute 
administration of high dietary sodium impairs EDD in healthy adults, independent of changes in 
blood pressure (39, 123).     
 There is little information in humans as to how excessive sodium intake causes vascular 
dysfunction.  However, data from rodents strongly support the idea that sodium suppresses 
EDD by reducing NO bioavailability as the result of oxidative stress (97, 140, 141), possibly via 
oxidation and reduced bioavailability of BH4 (98).  However, no direct evidence is available from 
humans as to the mechanisms by which DSR may improve vascular function, which is thus a 
central focus the focus of the present work.   
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Abstract  
OBJECTIVE: Age and increasing systolic blood pressure (BP) are associated with 
vascular endothelial dysfunction, but the factors involved are incompletely understood.  We 
tested the hypothesis that vascular endothelial function is related to dietary sodium intake 
among middle-aged and older adults (MA/O) with elevated systolic BP.   METHODS: Data were 
analyzed on 25 otherwise healthy adults aged 48-73 years with high normal systolic BP or stage 
I systolic hypertension (130-159 mmHg) and diastolic BP <99 mmHg.  Self-reported sodium 
intake was <100 mmol/d in 12 (7M) subjects (low sodium, 73±6 mmol/d) and between 100-200 
mmol/d in 13 (9M) subjects (normal sodium, 144±6 mmol/d).  RESULTS: Groups did not differ in 
other dietary factors, age, body weight and composition, BP, metabolic risk factors, physical 
activity and maximal aerobic capacity.  Plasma concentrations of norepinephrine, endothelin-1, 
oxidized LDL, antioxidant status and inflammatory markers did not differ between groups.  
Brachial artery FMD was 42% (mm∆) to 52% (%∆) higher in the low vs. normal sodium group 
(P<0.05).  In the entire cohort, brachial artery FMD was inversely related to dietary sodium 
intake (FMD mm∆ r=-0.40, P<0.05; %∆ r=-0.53, P<0.01).  Brachial artery FMD was not related 
to any other variable.  In contrast, endothelium-independent dilation did not differ between 
groups (P>0.24) and was not related to sodium intake in the overall group (P>0.29).  
CONCLUSIONS:  Low sodium intake is associated with enhanced brachial artery FMD in MA/O 
with elevated systolic BP.  These results suggest that dietary sodium restriction may be an 
effective intervention for improving vascular endothelial function in this high-risk group. 
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Introduction 
Cardiovascular diseases (CVD) remain the leading cause of death in modern societies 
and this is attributable in large part to dysfunction of the endothelial layer of arteries (13, 130).  
Aging is associated with development of vascular endothelial dysfunction and is a major risk 
factor for CVD (21, 74, 120).  Systolic blood pressure increases with age and contributes to the 
age-associated increase in CVD (74, 108).  Middle-aged and older adults with elevated systolic 
blood pressure demonstrate greater vascular endothelial dysfunction and risk of CVD than their 
peers with normal systolic pressure (118, 120).  Thus, identifying factors that influence vascular 
endothelial function in middle-aged and older adults with elevated systolic blood pressure has 
important clinical implications for preventing age-associated CVD. 
Indirect evidence suggests that dietary sodium intake may be one such factor.  Self-
reported sodium intake is positively related to CV outcomes among middle-aged and older 
adults (125) and blood pressure sensitivity to sodium increases with age in healthy adults (48, 
138).  In rodents, increased sodium intake causes impaired endothelium-dependent dilation, the 
most common measure of vascular endothelial dysfunction, independent of effects on arterial 
blood pressure (11, 97, 141).  In humans, impaired endothelium-dependent dilation is observed 
in young healthy men in response to acute sodium loading (123) as well as in patients with 
essential hypertension who demonstrate blood pressure sensitivity to changes in sodium 
compared with patients who are resistant to sodium (15, 77, 92).  Taken together, these 
observations suggest that middle-aged and older adults with lower dietary sodium intake may 
have enhanced vascular endothelial function compared with their peers with higher intake of 
sodium.  However, presently there are no data addressing this issue. 
 To test this hypothesis, we compared groups of unmedicated middle-aged and older 
adults with elevated baseline systolic blood pressure who consumed a diet either low or within 
the average range for sodium intake in the U.S.  The groups did not differ in blood pressure and 
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other subject characteristics, risk factors and diet composition (e.g., potassium intake) that could 
independently affect vascular endothelial function, allowing us, as much as is possible in an 
initial cross-sectional investigation, to isolate the effects of dietary sodium intake.  Brachial 
artery flow-mediated dilation (FMD), a measure of endothelium-dependent dilation, was used to 
assess vascular endothelial function.  Endothelium-independent dilation also was assessed as a 
control to ensure that any effect of dietary sodium intake on brachial FMD reflected an 
endothelium-dependent influence.   
 
Methods 
Subjects.  Subjects were 25 middle-aged and older (48-73 years) men (n=16) and 
postmenopausal women (n=9) with high normal systolic blood pressure or stage I systolic 
hypertension (130-159 mmHg).  Subjects had a diastolic blood pressure <99 mmHg and were 
otherwise free of cardiovascular diseases, diabetes and other clinical disorders as assessed by 
medical history, physical examination, blood chemistries and resting and exercise ECG.  All 
subjects were non-smokers, not taking medications (prescription or over the counter) or dietary 
supplements (including those with antioxidant properties) and not regularly exercising.  All 
procedures were approved by the Human Research Committee of the University of Colorado at 
Boulder.  The nature, benefits and risks of the study were explained to the volunteers and their 
written informed consent was obtained prior to participation.  
Study Procedures.  All measurements were performed at the University of Colorado at 
Boulder General Clinical Research Center (GCRC) after an overnight fast (water only) and a 24-
hour abstention from alcohol and vigorous physical activity.  
Group Selection.  Initially, subjects were identified from our laboratory database 
according to the inclusion/exclusion criteria described above.  Among subjects meeting those 
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criteria, individuals then were identified as having dietary sodium intake <100 mmol/d (low 
sodium) or between 100-200 mmol/d (normal sodium).  The upper cutoff for the low sodium 
group was based in part on the Dietary Reference Intake tolerable upper limit for sodium intake 
of 100 mmol/d (1) and to achieve a low sodium group mean value as close as possible to the 
Dietary Approaches to Stop Hypertension (DASH) recommended level of ~60 mmol/d (109).  
The range of 100-200 mmol/d was selected to provide a normal sodium group mean value 
consistent with the average American dietary sodium intake of ~150 mmol/d (133).   
Dietary Analysis.  Diet composition and caloric intake were estimated from 3-day food 
intake records (The Food Processor 8.2, ESHA Research) (99) (n=15, 7 low sodium/8 normal 
sodium) or food-frequency questionnaires (FFQ) (NHANES III food-intake database) (52) (n=10, 
5 low sodium/5 normal sodium) previously analyzed by a GCRC bionutritionist.  
Subject Characteristics and Blood Assays.  Body mass index (BMI) was calculated 
from height and weight to the nearest 0.1 kg, and waist and hip circumferences were measured 
by anthropometry (25).  Total body fat was determined using dual energy x-ray absorptiometry 
(DPX-IQ, GE/Lunar, Inc.) (25).  Arterial blood pressure was measured over the brachial artery 
during seated rest using a semi-automated device (Dynamap XL, Johnson and Johnson) (93).  
Habitual physical activity was assessed from estimates of daily energy expenditure using the 
Stanford Physical Activity Questionnaire as previously described (45).  Peak oxygen 
consumption was determined with on-line, computer-assisted, open-circuit spirometry and was 
used as a measure of maximal aerobic exercise capacity (38).   
All assays were performed by the University of Colorado GCRC core laboratory.  Plasma 
total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol 
(HDL-C), very low-density lipoprotein cholesterol (VLDL-C), triglycerides, glucose and insulin 
were determined using standard assays.  The homeostasis model of insulin resistance (HOMA-
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IR) was calculated by the formula: [fasting glucose (mg/dl) x fasting insulin μU/L)]/405 (14).  
Plasma norepinephrine concentrations were measured by high performance liquid 
chromatography.  Serum endothelin-1 (Peninsula Laboratories, Inc), oxidized LDL (Alpco, Inc), 
total antioxidant status (Randox Laboratories, Inc.), interleukin-6 (IL-6; R&D Systems, Inc) and 
tumor-necrosis factor-α (TNF-α) were measured by ELISA.  Serum concentrations of C-reactive 
protein were measured using a high-sensitivity Chemistry Immuno Analyzer (AU400e, Olympus 
America, Inc.). 
Brachial Artery FMD and Endothelium-Independent Dilation.  Brachial artery FMD 
(occlusion cuff on the upper forearm), peak shear rate during FMD, and endothelium-
independent dilation (brachial artery dilation in response to sublingual nitroglycerin) were 
determined using duplex ultrasonography (Power Vision 6000, Toshiba) with a linear array 
transducer as described previously by our laboratory (99, 102).  Responses are expressed as 
mm and percent change from baseline diameter (42).  Measurements were performed within 
two weeks of establishing baseline subject characteristics.       
Statistics.  Statistical analyses were performed with SPSS (version 16.0).  Group 
differences were determined by t-tests for independent sample comparisons. Pearson 
correlation analysis was used to assess bivariate relations of interest.  Statistical significance for 
all analyses was set at P < 0.05.  
 
Results 
Subject Characteristics and Circulating Humoral Factors.  Characteristics of the 
groups are shown in Table 1.  There were no differences in age, body mass, BMI, waist:hip 
ratio, percent total body fat, systolic and diastolic blood pressure, plasma lipids and lipoproteins, 
plasma glucose and insulin, HOMA, physical activity and peak oxygen consumption between 
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groups (all P>0.11).  Circulating humoral factors for the groups are shown in Table 2.  Plasma 
norepinephrine, endothelin-1, oxidized LDL, total antioxidant status, C-reactive protein, IL-6 and 
TNF-α did not differ between groups (all P>0.16).  
Table 1: Subject Characteristics 
Table 1.  Subject Characteristics    
 Normal Na+ Low Na+ P-value 
n (m/f) 13 (9/4) 12 (7/5)  
Age (years) 60±2   62±1 0.44 
Body Mass (kg) 84±3 80±7 0.61 
BMI (kg/m2) 28.1±0.7 26.3±1.3 0.22 
Waist:Hip Ratio  0.94±0.03 0.87±0.03 0.11 
Total Body Fat (%) 34±2 34±2 0.90 
Systolic BP (mmHg) 138±2  138±1  0.93 
Diastolic BP (mmHg) 81±2   79±2  0.68 
Total Cholesterol (mg.dL-1) 197±7   214±9  0.16 
LDL-C (mg.dL-1) 121±7   135±9  0.19 
HDL-C (mg.dL-1) 50±4 50±4 0.92 
VLDL-C (mg.dL-1) 26±3 28±5 0.71 
Triglycerides (mg.dL-1) 128±17 142±25 0.62 
Glucose (mg.dL-1) 95±3 95±3 0.91 
Insulin (µU/L) 7.2±1.6 8.3±1.9 0.66 
HOMA  1.76±0.46 2.08±0.58 0.67 
Physical Activity (MET hrs.wk-1) 78±23 42±19 0.24 
Peak VO2 (ml.kg-1.min-1) 26±1 25±1 0.82 
Data are mean  S.E.; BMI, body mass index; BP, blood pressure; LDL-C, low-density 
lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; VLDL-C, very low-density 
lipoprotein cholesterol; HOMA, insulin sensitivity index; (homeostasis model assessment); 
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physical activity, average daily leisure and occupational activity; MET, metabolic equivalent; 
VO2, volume of oxygen consumption  
 
Table 2: Circulating Humoral Factors 
Table 2.  Circulating Humoral Factors    
  Normal Na+ Low Na+ P-value 
Norepinephrine (pg/ml) 271±17 336±46 0.16 
ET-1 (pg/ml) 6.2±0.4 6.9±0.4 0.26 
Oxidized LDL (U/L) 56.1±3.0 63.9±6.2 0.25 
Total Antioxidant Status (mmol/L) 1.40±0.09  1.18±0.08  0.24 
C-reactive protein (mg/L) 0.76±0.06 0.84±0.22 0.68 
IL-6 (pg/ml) 1.8±0.4 1.3±0.1 0.23 
TNF-α (pg/ml) 1.7±0.2 1.4±0.1 0.24 
Data are mean  S.E. ET-1, endothelin-1; IL-6, interleukin-6; TNF-alpha, tumor necrosis 
factor-α  
  
Diet.  Diet composition of the groups is shown in Table 3.  Sodium intake was 144±6 
and 73±6 mmol/d for the normal and low sodium groups, respectively (P<0.0001).  Potassium 
and calcium intake, and carbohydrate, fat and protein composition did not differ between groups 
(all P>0.53).  Total energy intake tended to be lower in the low sodium group (P=0.07). 
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Table 3:  Subject Diet Composition 
Table 3.  Subject Diet Composition    
  Normal Na+ Low Na+ P-value 
Sodium Intake (mmol/d) 144+6   73+6  <0.01 
Potassium Intake (mmol/d) 66+8  64+9   0.89 
Calcium (mmol/d) 21±2 20±3 0.75 
Carbohydrates (% of total kilojoules/day) 52±3 53±2 0.69 
Fat (% of total kilojoules/day) 32±2 31±1 0.53 
Protein (% of total kilojoules/day)  16±3 16± 2 0.94 
Total Kilojoules/day  8709±475 7140±697 0.07 
Data are mean  S.E.  
 
 Brachial Artery FMD and Endothelium-Independent Dilation.  Baseline brachial 
artery diameter was smaller in the low compared with the normal sodium intake group 
(3.46+0.17 vs. 3.96+0.16 mm, P<0.05), whereas peak shear rate during FMD was similar in the 
two groups (392±57 vs. 384±42 sec-1, P=0.91).  Brachial artery FMD was 42% (mm∆) to 52% 
(%∆) higher in the low sodium compared with the normal sodium group (both P<0.05) (Figure 
1).  In contrast, endothelium-independent dilation did not differ between groups (P>0.24) (Figure 
1).  In all subjects, brachial artery FMD was inversely related to dietary sodium intake (%∆ r=-
0.53, P<0.01; mm∆ r=-0.40, P<0.05) (Figure 2).  Sodium intake was not related to endothelium-
independent dilation (P>0.29).  FMD and endothelium-independent dilation were not related to 
any other variable, including baseline brachial artery diameter and total kilojoules/day. 
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Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Endothelium-dependent dilation (brachial artery FMD; percentage change (%∆), 
absolute change (mm∆); top) in normal and low dietary sodium groups, and endothelium-
independent dilation (brachial artery dilation in response to sublingual nitroglycerin (NTG); 
bottom) in normal and low dietary sodium groups.  Values are mean  S.E. *P<0.05 vs normal 
sodium group.  
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Figure 2.    
 
                   
 
 
 
 
Figure 2.  Relation between brachial artery flow-mediated dilation (FMD; percentage change 
(%∆); left, absolute change (mm∆); right) and daily dietary sodium (Na+) intake. 
 
Discussion 
 To our knowledge this is the first study to report an association between vascular 
endothelial function and the normal dietary sodium intake of humans.  We found that in middle-
aged and older adults with elevated baseline systolic blood pressure, brachial artery FMD, a 
well-established measure of endothelium-dependent dilation and vascular endothelial function, 
was greater in those with low compared with average sodium intake based on U.S. norms.  
Consistent with these group differences, brachial FMD was inversely related to dietary sodium 
intake among individuals in the entire sample.  In contrast, no such relations were observed with 
endothelium-independent dilation.  Considered together, these findings indicate that sodium 
intake in the diet may exert an important influence on vascular endothelial function in this group. 
 Biomedical Significance.  Recent evidence suggests that self-reported sodium intake 
is positively related to the risk of CV events among middle-aged and older adults (125), 
suggesting a link with age-associated CVD.  Previous investigations in rodents and young adult 
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humans have established that experimentally increasing sodium intake or sodium loading 
results in impaired vasodilatory responses to the endothelium-dependent dilator, acetycholine 
(11, 97, 123).   
The present findings extend and complement these earlier observations by 
demonstrating that in middle-aged and older adults with elevated systolic blood pressure, a 
group with baseline vascular endothelial dysfunction and increased risk of CVD, brachial artery 
FMD is inversely related to self-reported dietary sodium intake.  Importantly, our results show 
that the relation between sodium intake and vasodilatory responsiveness is specific to the 
vascular endothelium, as endothelium-independent dilation did not differ between the low and 
normal sodium intake groups, nor was it related to sodium intake among individual subjects.  
Our findings also are important because brachial artery FMD predicts future risk of CV events in 
middle-aged and older adults (130, 135).  Overall, the present results provide new clinical 
insight that vascular endothelial dysfunction is a possible intermediary pathophysiological 
mechanism linking dietary sodium intake to future CV events in middle-aged and older adults 
(125). 
Findings from studies in which endothelium-dependent dilation was assessed under 
experimentally controlled sodium intake conditions in humans have been inconsistent.  No 
effects of dietary sodium restriction on the forearm blood flow responses to acetylcholine was 
observed in patients with sodium-sensitive or -resistant forms of essential hypertension (67, 92), 
whereas brachial artery FMD was improved in overweight and obese adults with normal blood 
pressure (40).  The results of the present study are in agreement with the latter investigation, 
which, together, support an association between dietary sodium intake and brachial artery FMD 
in groups with impaired baseline function. 
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Physiological Influence of Sodium Intake.  The influence of sodium intake on brachial 
artery FMD in our study appears to be physiologically significant.  Depending on which of the 
two standard clinical expressions of FMD are used (mm∆ or %∆), the low vs. normal sodium 
intake group differences were 42-52%.  Moreover, a moderately strong correlation coefficient of 
r=-0.53 was observed for the relation between brachial FMD and sodium intake among all 
subjects.  As with most correlations, this correlation coefficient likely significantly underestimates 
the true physiological relation between endothelium-dependent dilation and dietary sodium 
intake because of the inherent measurement error associated with each of the variables.   
In a recent investigation by our laboratory using the same procedures as in the present 
study, we reported a mean %∆ brachial FMD of 7.2% in healthy young adult men and women 
with normal blood pressure (n=62) (102).  In comparison, the values for the low and normal 
sodium intake groups in the present study were 5.0% and 3.3%, i.e., 30% vs. 55% lower, 
respectively, than the values for young healthy controls.  Together, these observations suggest 
that although brachial artery FMD is impaired in middle-aged and older adults with elevated 
systolic blood pressure regardless of dietary sodium intake, those consuming a diet <100 
mmol/d in sodium demonstrate less impairment than those consuming even average amounts 
of sodium. 
 Strengths of the Study Design.  A major strength of our study was that the low and 
normal sodium intake groups were carefully selected for similar subject characteristics (e.g., 
body fatness, physical activity, maximal aerobic capacity) and coronary risk factors (e.g., 
plasma lipids and lipoproteins, fasting glucose and insulin) (Table 1) that could independently 
influence brachial FMD.  This allowed us to isolate the effects of sodium intake as much as is 
possible using cross-sectional group comparisons.  Consistent with observations in rodents (12, 
84) , arterial blood pressure was similar in our two groups and, thus, cannot explain the 
differences in brachial artery FMD.  Several other dietary factors that could influence 
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endothelium-dependent dilation also were controlled for, including potassium intake (Table 3).  
This experimental approach resulted in smaller group sizes, but allowed much clearer 
interpretation of our results than would otherwise be possible.  Although estimated total energy 
intake and brachial artery baseline diameter tended to be or were significantly different, 
respectively, in the 2 groups, neither was related to FMD. 
 Limitations of the Study.  There are several limitations of our study that we wish to 
emphasize.  We only can provide limited insight into the mechanisms by which low sodium 
intake was associated with enhanced vascular endothelial function.  Results from studies in 
rodents suggest that sodium intake may be positively related to oxidative stress, which limits 
nitric oxide bioavailability and impairs endothelium-dependent dilation (97, 140, 141).  In the 
present study, plasma oxidized LDL, an indirect measure of oxidative stress, and plasma total 
antioxidant status did not differ between groups.  Plasma concentrations of norepinephrine, a 
measure of sympathetic nervous system activity, endothelin-1, a potent vasoconstrictor 
produced by the vascular endothelium, and the inflammatory markers C-reactive protein, IL-6 
and TNF-α also did not differ between groups. However, these plasma measures do not 
necessarily reflect differences in the vascular endothelium that would directly influence FMD, 
particularly among a relatively homogeneous group of adults such as those studied here.   
Our subjects were otherwise healthy middle-aged and older adults with elevated systolic 
blood pressure and, therefore, likely to be more sensitive to sodium than younger adults with 
normal blood pressure.  As a result, the relation we observed between brachial FMD and 
sodium intake may not be apparent in younger adults, as sodium-sensitivity increases with age 
(48, 138).   
In the present study we were able to determine the influence of low compared with 
average sodium intake.  However, we did not have sufficient data on subjects with higher 
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sodium intake who fit our eligibility requirements to compare with the low and average sodium 
intake groups.  As such, we do not know if higher than average sodium intake is associated with 
greater impairments in brachial FMD in this population. 
Baseline brachial artery diameter was smaller in the low sodium group, likely because of 
the slightly higher percentage of female subjects compared with the normal sodium group.  
However, it is unlikely that this confounded the interpretation of our results.  First, FMD was not 
related to baseline diameter.  Second, if smaller baseline diameter per se contributed to greater 
FMD we also would expect to see this effect in endothelium-independent dilation, which was not 
the case.  Last, FMD in percent change accounts for differences in baseline diameter and group 
differences in FMD also were observed with this expression. 
Shear rate produced by the hyperemic stimulus also influences FMD.  We do not believe 
this factor explains our group differences in FMD as shear rate did not differ between groups 
and was not related to FMD among individuals.  Moreover, Donald et al. (42) recently 
established that percent and absolute change in FMD are the most sensitive and reproducible 
expressions of FMD for depicting differences among groups.    
Abdominal fat generally is inversely related to FMD (17) and there was a non-significant 
(P=0.11) trend for waist:hip ratio to be smaller in our low sodium group (possibly due to a 
slightly higher percentage of females).  However, waist:hip ratio was not related to FMD.  
Percent body fat was identical in the two groups.  
Finally, the available methods of assessing dietary sodium intake in our subjects were 
limited because of the retrospective nature of the data analysis.  Sodium intake was assessed 
using two different methods, and urinary sodium excretion, an objective measure of sodium 
intake (32), was available on only a small number of the total subjects (n=6).  Despite these 
limitations, we were able to show associations between brachial artery FMD and sodium intake 
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in group comparisons and among individuals.  Diet composition assessed using FFQ and 3-day 
diet records generally are in agreement (10, 88, 89), and the % of subjects in each group 
assessed with these instruments was similar in the present study.  Moreover, sodium intake 
measured by these self-report instruments correlates with urinary sodium excretion (19, 33, 79, 
90).  In a separate group of 32 middle-aged and older adults (mean 60±1 years, 17M/15F) in 
whom we previously had obtained one of these self-report measures of sodium intake and 
urinary sodium excretion, we found surprisingly similar mean values of 126±10 vs. 127±10 
mmol/d, respectively, between the two methods.  
Summary and Conclusions.  In summary, the results of our study suggest that low 
sodium intake is associated with enhanced brachial artery FMD in middle-aged and older adults 
with elevated systolic blood pressure.  As such, our findings provide evidence for a possible link 
between dietary sodium intake, the development of vascular endothelial dysfunction and 
increased risk of CVD in this group.  Importantly, our results and those of others (40) provide an 
experimental basis for conducting an intervention trial aimed at determining the efficacy of 
dietary sodium restriction for improving vascular endothelial function in this group, as previously 
demonstrated for large elastic artery stiffness (59). 
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Abstract 
Background:  Vascular endothelial dysfunction increases with advancing age and 
elevated systolic blood pressure (SBP), thus interventions that may improve function in this 
group are clinically significant.  I tested the hypothesis that dietary sodium restriction would 
improve vascular endothelial dysfunction (assessed by endothelium-dependent dilation, EDD) in 
middle-aged and older adults with moderately elevated SBP (130-159 mmHg) by increasing 
nitric oxide (NO) and tetrahydrobiopterin (BH4) bioavailability and reducing oxidative stress.  
Methods and Results: EDD, measured by brachial artery flow-mediated dilation (FMDBA) and 
forearm blood flow to acetylcholine (FBFACh), was 71% and 53% (peak FBFACh) higher following 
4 weeks of a low sodium (70+8 mmol/day) vs. normal sodium (153+7 mmol/day) diet (p<0.05; 
randomized, cross-over design; 9M/5F; 61+2 yrs), whereas endothelium-independent dilation 
(brachial artery dilation to nitroglycerin and FBF to sodium nitroprusside) did not differ between 
conditions (p>0.50).  Compared to normal sodium, low sodium increased NO bioavailability 
(significant reduction in FBFACh  with co-infusion of an endothelial nitric oxide synthase inhibitor), 
increased BH4 bioavailability (FMDBA no longer improved with oral BH4) and reduced oxidative 
stress (FMDBA and FBFACh no longer improved with ascorbic acid infusion; reduced endothelial 
cell nitrotyrosine abundance) (p<0.06).  These differences remained when correcting for SBP, 
and other subject characteristics/dietary factors did not change across conditions.  
Conclusions:  These results indicate that dietary sodium restriction reverses vascular 
endothelial dysfunction in middle-aged and older adults with moderately elevated SBP by 
enhancing NO and BH4 bioavailability and reducing oxidative stress, thus the physiological 
mechanisms modulating benefits are beyond BP lowering alone.   
 
 
 
34 
 
Introduction  
Cardiovascular diseases (CVD) remain the leading cause of death in the United States, 
and risk of CVD increases progressively with age (73, 107).  Endothelial dysfunction, commonly 
assessed as a decline in endothelium-dependent dilation (EDD), is a clinically important 
predictor of future CVD and/or CV events (13, 63, 130).  Whether assessed as brachial artery 
flow-mediated dilation (FMDBA) or as the forearm blood flow response to acetylcholine (FBFACh), 
EDD is reduced in middle-aged and older adults (22, 120).  Systolic blood pressure (SBP) also 
increases with advancing age (74), and the age-associated reduction in EDD is even greater in 
individuals with essential hypertension (37, 113, 119).  Thus, interventions that may improve 
vascular endothelial dysfunction in middle-aged and older adults with moderately elevated SBP 
are clinically significant.  
Dietary sodium restriction is a promising lifestyle modification for preventing CVD.  As 
recently stressed by the American Heart Association, the projected health and societal benefits 
resulting from population-wide dietary sodium restriction are substantial (8).  To date, such 
projections have focused on the effects of sodium restriction on blood pressure.  However, 
independent of its effects on blood pressure, high dietary sodium contributes to other adverse 
cardiovascular outcomes (39, 57, 110).  The evidence supporting the relation between sodium 
and endothelial function has been largely based on animal literature or acute salt loading/cross-
sectional observations in humans (11, 39, 69, 123, 141).  It is presently unknown if dietary 
sodium restriction can attenuate the age- and elevated blood pressure-associated decline in 
vascular endothelial function.   
The physiological mechanisms by which dietary sodium restriction may modulate 
vascular endothelial function in humans are also widely unknown.  The available data from 
rodents support the idea that sodium suppresses EDD by reducing nitric oxide (NO) 
bioavailability as the result of oxidative stress (97, 140, 141), possibly via oxidation and reduced 
bioavailability of tetrahydrobiopterin (BH4) (98).  Thus, dietary sodium restriction may improve 
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EDD by modulating one or more of these factors.  If sodium restriction indeed improves vascular 
endothelial function via physiological mechanisms other than blood pressure lowering alone, the 
potential impact of reducing dietary sodium consumption upon risk of CVD may be even greater 
than presently appreciated.    
Thus, the aim of the present study was to determine if dietary sodium restriction 
improves EDD in middle-aged and older adults with moderately elevated SBP and the 
physiological mechanisms modulating any functional improvements.  Using a double-blind, 
placebo-controlled, randomized, crossover design, I assessed EDD and associated 
physiological mechanisms under conditions of low and normal dietary sodium intake.  A low 
sodium target of 1,200 mg/day (50 mmol/day) was set, with the anticipation that actual mean 
intake would fall at ~1,500 mg/d (65 mmol/day), consistent with sodium intake in the Dietary 
Approaches to Stop Hypertension (DASH) diet (109), as well as recent AHA recommendations 
(4).  This was compared to a typical (e.g. normal sodium) American intake of 3,600 mg/day (150 
mmol/day), similar to recent National Health and Nutrition Examination Survey (NHANES) mean 
intake data (124).  I present here novel findings that a low sodium diet reverses endothelial 
dysfunction by increasing NO and BH4 bioavailability and reducing oxidative stress. 
 
Methods 
Subjects.  Subjects were 14 middle-aged and older (51-77 years) men (n=9) and 
postmenopausal women (n=5).  Resting SBP was 130-159 mmHg (i.e. high normal or stage I 
hypertension) and diastolic blood pressure was <99 mmHg, verified on a minimum of two 
occasions.  Those taking antihypertensive medications were included in the study if blood 
pressure still fell within the inclusion range despite medication use, because dietary sodium 
restriction reduces SBP even in subjects on blood pressure lowering medications (103).  Thus, it 
was reasonable to assume that such individuals were as likely to benefit from the present 
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intervention as those not on antihypertensive medications.  All subjects were otherwise free of 
CVD, diabetes, kidney disease and other clinical disorders as assessed by medical history, 
physical examination, ankle-brachial index (<0.9), blood chemistries and resting and exercise 
ECG.  All subjects were non-smokers, had a body-mass index (BMI) <40 and were not taking 
hormone replacement therapy or dietary supplements known to influence vascular function 
(including those with antioxidant properties).  Subjects were either sedentary or recreationally 
active, but not aerobically trained.  All procedures were approved by the Institutional Review 
Board of the University of Colorado at Boulder.  The nature, benefits and risks of the study were 
explained to the volunteers and their written informed consent was obtained prior to 
participation.  
Experimental Design.  I used a double-blind, placebo-controlled, randomized, 
crossover design originally described by Cappuccio et. al. (20) and more recently by our 
laboratory (59).  During a ten week intervention period, subjects reduced dietary sodium intake 
to a target of ~50 mmol/day and were asked to take a total of ten tablets spread across the day 
with meals.  For five of the weeks the tablets were placebo pills, and for the other five weeks the 
tablets were slow-release sodium chloride tablets (10 mmol (0.23 g) per tablet) (HK Pharma, 
UK).  The slow-release salt tablets aimed to return sodium intake to ~150 mmol/day, consistent 
with a “normal” sodium intake for an American diet (124).  Weekly visits were made during the 
study to the University of Colorado at Boulder Clinical and Translational Research Center 
(CTRC) for nutritional consultation to assure adherence to the diet.  Vascular measurements 
were performed after four weeks (i.e. during the fifth week) of each condition following an 
overnight fast (water only) and a 48-hour abstention from non-prescription medications and a 
24-hour abstention from alcohol, vigorous physical activity and prescription medications 
(including antihypertensive medications).  Results are presented for all fourteen subjects except 
when indicated (due to failed procedures such as arterial catheterizations, venous blood draw, 
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etc.).  Subjects completing a given procedure at one time-point (i.e. low sodium or normal 
sodium condition) only were included in analyses in accordance with intent to treat. 
Dietary Sodium Restriction.  Following screening, subjects were provided with 
comprehensive dietary education and counseling by a CTRC bionutritionist to reduce dietary 
sodium intake without changing caloric intake, dietary composition or potassium intake.  After 
the initial education session, subjects met weekly throughout the ten week intervention period 
with the bionutritionist.  Each week, blood pressure, body mass and 24-hour urinary sodium and 
potassium excretion were assessed. 
Casual Blood Pressure Measures.  Resting casual brachial artery blood pressure 
measurements were made in a supine position using a semi-automated device (Dynamap XL, 
Johnson and Johnson) after >1 hr abstention from caffeine and exercise, in accordance with the 
Joint National Committee (24), as described previously (59, 68).  The average of three readings 
within 5 mmHg following 15 minutes of rest was recorded.  Blood pressure was assessed 
weekly during the first 4 weeks of each condition and on three separate days during each 
testing week (the mean value across all three days is reported).  We have previously shown that 
reductions in blood pressure with sodium restriction are the same whether assessed with 
random zero sphygmomanometry or using a semi-automated device, and that ambulatory blood 
pressure is also reduced (59). 
 Dietary Analysis.  Subjects were instructed how to keep 3-day dietary records by a 
CTRC bionutritionist.  Records were analyzed using Food Processor software (ESHA Research) 
at baseline and at the end of each condition of the intervention, as described previously (59). 
Subject Characteristics and Blood Assays.  To explore any influence of body 
composition upon responsiveness to a low sodium diet, body-mass index (BMI) was determined 
at baseline using height and weight to the nearest 0.1 kg, waist and hip circumferences were 
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measured by anthropometry and total body fat was determined using dual energy x-ray 
absorptiometry (DPX-IQ, GE/Lunar, Inc.) (99).  As we have previously demonstrated that a low 
sodium diet does not alter body composition (59), only BMI and not total body fat measurements 
were repeated during the intervention period.   
   Subjects were asked not to alter their usual physical activity during the study.  Habitual 
physical activity was assessed during each sodium condition using a) estimates of daily energy 
expenditure using the Stanford Physical Activity Questionnaire as previously described (45) and 
b) weekly kilocalorie expenditure measured by ActiGraph accelerometers (Model GT3X, 
ActiGraph, LLC, Fort Walton Beach, FL) recording physical activity at a rate of 30 HZ (60 
second epochs) (n=7). 
24-hr urinary sodium and potassium excretion were measured by Boulder Community 
Hospital once a week during the first four weeks and twice (the mean is presented) at baseline 
and during the testing week of each sodium condition.  All blood assays were performed by the 
University of Colorado CTRC core laboratories or Boulder Community Hospital (n=13).  Plasma 
total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol 
(HDL-C), triglycerides, glucose, insulin and plasma sodium were determined using standard 
assays.  Estimated glomerular filtration rate (eGFR) was calculated using the Modification of 
Diet in Renal Disease (MDRD) formula: 186.3 x (serum creatinine) -1.154 x age -0.203 x (0.742 for 
women), with serum creatinine measured using an enzymatic assay (Beckman Coulter Inc.) 
(82).    
  Glutathione peroxidase was determined with the Mira method and total antioxidant 
status was measured using a commercial kit (both Randox Laboratories, Inc.).  Serum oxidized 
LDL (Mercodia), interleukin-6 (IL-6; R&D Systems, Inc), tumor-necrosis factor-α (TNF-α, R&D 
Systems, Inc) and endothelin-1 (n=7) (R&D Systems, Inc), were measured by ELISA.  
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Extracellular superoxide dismutase (ecSOD) activity was measured in the plasma at rest using 
a commercially available colimetric kit (Cell Technology), as described previously (n=10 low 
sodium / n=9 normal sodium) (76).  Serum concentrations of high sensitivity C-reactive protein 
were measured using the immunoturbidimetric method (Beckman Coulter).  Angiotensin II 
(Evaluating Data), plasma renin activity (DiaSorin) and aldosterone (Diagnostic Products, Corp.) 
were measured using conventional radioimmunoassays.  Plasma norepinephrine concentrations 
were measured by high performance liquid chromatography (BioRad Laboratories).  Cystatin C 
was measured using a commercially available particle-enhanced immunonephelometric assay 
(Dade-Behring).  
Brachial Artery FMD and Endothelium-Independent Dilation.  Brachial artery flow-
mediated dilation (FMDBA) (occlusion cuff on the upper forearm), peak shear rate during FMDBA 
and endothelium-independent dilation (brachial artery dilation in response to 0.4 mg of 
sublingual nitroglycerin; NTG) were determined using duplex ultrasonography (Power Vision 
6000, Toshiba) with a linear array transducer as described previously by our laboratory (68, 99, 
100, 102).  Baseline, occlusion (i.e. the average diameter for the 15 s immediately before rapid 
cuff deflation) and peak brachial artery diameters were analyzed using commercially available 
software (Vascular Research Tools 5.0; Medical Imaging Applications) by the same investigator, 
who was blinded to the subject group assignment.  Pulsed Doppler signals were recorded at an 
angle of insonation of < 68 ̊ with a sample volume the entire width of the artery, as described 
previously (100).  Time-averaged peak velocity was obtained from recording the first ten velocity 
envelopes.  Brachial artery peak hyperemic shear rate was calculated as 8 times (due to wide 
sample volume) the peak velocity immediately following 5 min of forearm occlusion, divided by 
occlusion diameter (n=11).  Responses are expressed as mm and percent change from 
baseline diameter (42).   
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Tetrahydrobiopterin (BH4)  modulation of EDD was determined by measuring FMDBA ~3 
hrs after oral administration of BH4 or placebo tablets, when BH4 reaches its maximal plasma 
concentration, as described previously (52, 101) (n=12 low sodium / n=13 normal sodium).  
Because the key comparison was the BH4-placebo difference in FMDBA during low vs. normal 
dietary sodium intake states, the order of the placebo (first) and BH4 (second) sessions was 
standardized (blinded to subject).  Standardizing the order, under these particular conditions, 
eliminated the measurement variability that would be introduced by randomization.  BH4 is 
presently only available for oral administration, thus was used to assess modulation of FMDBA 
but not local FBFACh.  Endothelium-independent dilation to sublingual NTG was also assessed 
during BH4 and placebo sessions (n=14 low sodium / n=13 normal sodium, placebo; n=8 low 
sodium / n=6 normal sodium, BH4).    
The influence of oxidative stress on FMDBA on each of these days (BH4 and placebo)  
was determined by infusing a supraphysiological dose of ascorbic acid (American Regent 
Laboratories Inc., Shirley, NY) or isovolumic saline as described previously by our laboratory 
and others (50, 51, 95, 118).  A priming bolus of 0.06 g ascorbic acid/kg fat-free mass dissolved 
in 100 mL of saline was infused intravenously at 5 mL/min for 20 min, followed immediately by a 
“drip-infusion” of 0.02 g/kg fat-free mass dissolved in 30 mL of saline administered over 60 min 
at 0.5 mL/min.  Vascular measurements were made at the end of the 20 min bolus during the 
“drip infusion”, when peak plasma concentrations of ascorbic acid occur (51) (n=14 low sodium / 
n=13 normal sodium, placebo; n=10 low sodium / n=12 normal sodium, BH4).    
Forearm Blood Flow Assessment of EDD and Endothelium-Independent Dilation.  
FBF was measured in the experimental (catheterized) and the control forearm with strain-gauge 
venous occlusion plethysmography (AI6 Arterial Inflow System, Hokanson), as previously 
described (38, 44).  Briefly, a mercury-Silastic strain gauge was placed around the forearm, and 
a cuff was placed around each upper arm and repeatedly inflated to 60 mmHg to occlude 
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venous outflow for 7 s.  A second cuff was placed around the wrist and inflated to suprasystolic 
pressures to exclude the hand circulation during FBF measures.  Flows were measured during 
the last minute of each 3-min dose, and the mean value is reported.  All FBF values are 
presented as percent increase in flow (ml · 100 ml forearm tissue-1 · min-1) compared to saline 
control.  Forearm vascular conductance (FVC) was calculated from intra-arterial blood pressure 
and FBF (FVC=FBF/mean arterial pressure) to account for any differences in arterial blood 
pressure between sodium conditions.   
Forearm volume was determined by the water displacement method.  Drug infusion 
rates were normalized per 100 ml of forearm tissue and infused at <4 ml/min by a syringe pump 
(Harvard).  EDD and endothelium-independent dilation were determined as the FBF responses 
to an incremental intrabrachial artery infusion of acetylcholine (ACh) (1.0, 2.0, 4.0, and 8.0 µg · 
100 ml forearm tissue-1 · min-1) and sodium nitroprusside (0.5, 1.0, and 2.0 µg · 100 ml forearm 
tissue-1 · min-1), respectively  (n=11 low sodium / n=12 normal sodium).  To determine the effect 
of dietary sodium restriction on the nitric oxide (NO) contribution to EDD, NG monomethyl-L-
arginine (L-NMMA, 5 mg/min, 10-min loading dose) was co-infused with ACh (same doses as 
above).  This dose of L-NMMA inhibits NO production by competitive inhibition of endothelial 
NO synthase (eNOS) in the human forearm without causing systemic effects (41).  As L-NMMA 
must be infused locally to avoid systemic changes in blood pressure, it was only co-
administered during assessment of FBFACh and not during measurement of FMDBA. 
Endothelial Cell Protein Expression.  The procedures used for collection of arterial 
endothelial cells and measurement of protein expression using immunofluorescence have been 
described in detail previously by our laboratory (43, 45, 68, 102).  Briefly, J-wires were 
advanced into the brachial artery ~4 cm beyond the tip an 18-guage catheter and withdrawn.  
Cells were recovered by washing and centrifugation, fixed with 3.7% formaldehyde and plated 
on slides.  Non-specific binding sites were blocked with 5% donkey serum (Jackson 
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Immunoresearch) and cells were incubated with monoclonal antibodies for nitrotyrosine 
(Abcam), total eNOS and eNOS phosphorylated at Ser 1177 (BD Biosciences) (n=11 low 
sodium / n=12 normal sodium).    
Slides were systematically viewed with a fluorescence microscope (Eclipse 600, Nikon, 
Melville, NY) to identify endothelial cells (positive staining for VE cadherin) and nuclear integrity 
was confirmed with DAPI (4',6'-diamidino-2-phenylindole hydrochloride) staining.  Images were 
then captured and analyzed with Metamorph Software (Universal Imaging Corp, Downington, 
PA) to quantify the intensity of CY3 staining (i.e., average pixel intensity).  The values for each 
protein are reported as a ratio of arterial endothelial cell to human umbilical vein endothelial cell 
(HUVEC) average pixel intensity, which minimizes the possible confound of differences in 
staining intensity among different staining sessions.  A single investigator analyzed each batch 
of cells and was blinded to subject identification.   
Statistics.  The changes in EDD in response to dietary sodium restriction (normal vs. 
low sodium intake) were analyzed in a mixed-effects regression model with factors for condition 
(normal vs. low sodium), drug (ascorbic acid, BH4 (FMDBA); ascorbic acid, L-NMMA (FBFACh)), 
and dose (FBFACh only).  There was no evidence of a carryover effect, thus sequence of the 
intervention (low vs. normal sodium first) was not included in the model.  Covariates, such as 
systolic blood pressure, were included in the model as appropriate.  Differences in other 
outcomes and characteristics between sodium conditions/vs. baseline were assessed using 
paired t-tests (between sodium conditions) or repeated measures ANOVA with post-hoc 
Bonferonni corrected comparisons (sodium conditions vs. baseline).  C-reactive protein, IL-6 
and TNF-α were logarithmically transformed to improve the normality of these distributions.  The 
bivariate relations between FMDBA and urinary sodium excretion and SBP were determined 
using Pearson correlation coefficient.  Statistical significance for all analyses was set at P < 
0.05.  All data are reported as means + S.E.  
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Results 
Subject Characteristics and Dietary Sodium Restriction.  Subject characteristics 
prior to the start of the dietary intervention are presented in Table 1.  86% of the subjects were 
non-Hispanic Caucasian and 14% were Asian.  Three of the fourteen subjects were on an anti-
hypertensive medication.  Subjects successfully reduced sodium intake (152+11 mmol/d, 
baseline; 153+7 mmol/d, normal sodium condition (week 5); 70+8 mmol/d, low sodium condition 
(week 5)) without altering potassium intake (Figure 1).  As anticipated, SBP was reduced during 
the low vs. normal sodium condition, but other characteristics did not change (Table 2; values 
are for week 5).  The low sodium condition also reduced SBP as assessed during the first four  
weeks of the intervention (p<0.05 vs. NS; not shown).  Dietary composition other than sodium 
intake did not change (Table 3).  Circulating markers of oxidative stress, inflammation, the renin 
angiotensin aldosterone system, endothelin-1, norepinephrine, cystatin-C and insulin were also 
unchanged with the low sodium diet (Table 4).  
 
Table 1: Baseline Characteristics  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are mean + S.E.  ACE, angiotensin converting enzyme.   
Baseline Characteristics Baseline 
n (m/f) 14 (9/5) 
Age (years) 61+2 
Body Fat (%) 29+3 
Waist Circumference (cm) 88+3 
Waist:Hip (ratio) 0.87+0.03 
Medication Use Hypothyroidism drugs (n=3)   
ACE-inhibitor (n=1)                 
Ca2+ channel blocker (n=1) 
Diuretic (n=1)                            
Anti-depressant (n=1) 
44 
 
Figure 1.   
 
 
Figure 1.  24-hour urinary excretion of sodium (panel A) and potassium (panel B) at baseline  
 (B), weeks 1-5 of the normal sodium condition (N1-N5) and weeks 1-5 of the low sodium 
condition (L1-L5).  Values are mean  S.E.; * P<0.05 vs. normal sodium of same week; † 
P<0.01 vs. normal sodium of same week; ‡ P<0.01 vs. baseline.  
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Table 2: Subject Characteristics 
Data are mean + S.E.  * P<0.05 vs. baseline or NS.  BMI, body mass index; LDL, low-density 
lipoprotein; HDL, high-density lipoprotein; PA, physical activity; MET, metabolic equivalent; 
eGFR, estimated glomerular filtration rate (Modification of Diet in Renal Disease (MDRD) Study 
Equation). 
 
 
 
 
 
 
Subject Characteristics Baseline LS NS 
Body Mass (kg) 78.4+4.3 77.2+4.3 77.6+4.3 
BMI (kg.m2) 26.6+1.0 25.9+1.1 26.0+1.1 
Systolic Blood Pressure (mmHg) 139+2 128+3* 140+4 
Diastolic Blood Pressure (mmHg) 83+2 79+2 81+2 
Total Cholesterol (mg.dL-1) 194+8 184+8 193+6 
LDL Cholesterol (mg.dL-1) 121+6 114+6 125+7 
HDL-Cholesterol (mg.dL-1) 52+5 50+5 50+4 
Triglycerides (mg.dL-1) 110+18 99+12 93+13 
Fasting Glucose (mg.dL-1) 83+5 84+4 82+4 
24-hr Urinary Creatinine Excretion (mg.d-1) 1382+78 1304+85 1297+103 
PA (Actigraph) (kcals.wk-1) N/A 3137+290 3129+360 
PA (questionnaire) (MET hrs.wk-1) 40+11 28+8 29+8 
Plasma Sodium (mmol) 139.2+0.7 137.9+0.9 139.0+0.5  
MDRD eGRF (mL.min-1. 1.73m2) 83+4 83+4 88+6  
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Table 3: Diet Composition 
Data are mean + S.E; * P<0.01 vs. baseline.  † Note, sodium intake is based on 3-day diet 
records and excludes sodium added back in pill form.   
 
 
 
 
 
 
 
 
 
 
 
Diet Composition  Baseline LS NS 
Total kcals per day 2100+112 2037+146 1989+122 
Carbohydrates (g.day-1) 249+12 258+21 247+16 
Protein (g.day-1) 88+6 76+6 83+4 
Fat (g.day-1) 76+8 69+10 71+12 
Calcium (mmol.day-1) 23+2 18+2 20+1 
Magnesium (mmol.day-1) 11+1 11+1 10+1 
Potassium  (mmol.day-1) 63+5 65+5 67+5 
Sodium (mmol.day-1) † 130+11 56+4* 59+3* 
Fruits and Vegetables (cups.day-1)  3.7+0.6 3.8+0.4 4.1+0.5 
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Table 4: Circulating Humoral Factors 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are mean + S.E.  LDL, low-density lipoprotein; ecSOD, extracellular superoxide dismutase. 
 
 
 
 
 
 
 
 
Circulating Humoral Factors LS NS P-value 
Glutathione Peroxidase (U.L-1) 8032+861 7769+742 0.82  
Oxidized LDL (U.L-1) 43.6+2.6 40.0+2.5 0.32 
Total Antioxidant Status (mmol. L-1) 1.45+0.03 1.42+0.03 0.34  
ecSOD Activity (% inhibition rate) 59.7+1.8 57.2+1.6 0.32  
Log C-Reactive Protein (mg.L-1) 0.27+0.15 0.13+0.15 0.53 
Log Interleukin-6 (pg.mL-1) 0.11+0.06 0.05+0.09 0.61 
Log Tumor Necrosis Factor α (pg.mL-1) 0.07+0.03 0.08+0.04 0.87 
Angiotensin II (pg.mL-1) 5.3+0.7 4.6+0.6 0.44 
Plasma Renin Activity (ng.mL-1.hr-1) 0.76+0.3 0.49+0.1 0.46 
Aldosterone (ng.dL-1) 4.4+0.7 3.0+0.5 0.11  
Endothelin-1 (pg.mL-1) 5.8+0.5 6.8+0.5 0.19  
Norepinephrine (pg.mL-1) 398+51 406+40 0.91 
Cystatin C ( mg.L-1) 0.71+0.03 0.72+0.03 0.75 
Insulin (µU.mL-1) 11.1+1.2 9.0+0.9 0.20 
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Dietary Sodium Restriction Improved FMDBA without Changing Endothelium-
Independent Dilation to Sublingual NTG.  FMDBA (%∆) was 71% greater under the low 
sodium vs. normal sodium condition (6.11+0.62 vs. 3.57+0.44; p<0.01; Figure 2, panel A).  
Results were similar when expressed as mm change (0.23+0.02 vs. 0.14+0.02; p<0.01).  The 
individual subject response to dietary sodium restriction is shown in Figure 2, panel B, 
demonstrating improved FMDBA in 12 of the 14 subjects.  Panel C displays a significant inverse 
relation between sodium excretion and FMDBA with data points across the two sodium 
conditions pooled (r=-0.51, p<0.01).  Baseline diameter and shear rate did not differ across 
sodium conditions or with ascorbic acid and/or BH4 administration (p>0.21; not shown).  There 
was a significant interaction term between sodium condition and the following characteristics: 
gender, medication use and anti-hypertensive medication use.  Females and those on 
medications/blood pressure lowering medications tended to be more responsive to dietary 
sodium restriction; p<0.01.  When co-varying for all of these factors, FMDBA was still significantly 
greater during the low sodium condition (p<0.01).  The difference across sodium conditions 
remained significant when SBP was added as a covariate (p<0.01), and the change in SBP with 
sodium restriction was not correlated with the change in FMDBA (r=-0.05, p=0.86).  In contrast to 
FMDBA, endothelium-independent dilation to sublingual NTG was unchanged by dietary sodium 
restriction (Figure 2, panel D; %∆; mm∆ not shown; p>0.50). 
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Figure 2.   
                
Figure 2.  Brachial artery FMD (percent change (%∆), panel A) during the normal vs. low 
sodium condition; individual subject FMD (%∆) response between sodium conditions (panel B); 
relation between 24-hour urinary sodium excretion and FMD (%∆) with pooled sodium 
conditions (panel C); brachial artery endothelium-independent dilation to sublingual nitroglycerin 
(NTG) during the normal vs. low sodium condition (percent change (%∆), panel D).  Values are 
mean  S.E.; NS, normal sodium; LS, low sodium; *P<0.01 vs. NS.   
   
Dietary Sodium Restriction improved FBFACh without Changing in Endothelium-
Independent Dilation (FBF to Sodium Nitroprusside).  The low sodium condition improved 
EDD to ACh (% increase vs. saline control), whether expressed as FBF (53% increase at peak 
dose) or as the blood pressure corrected expression, forearm vascular conductance (68% 
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increase at peak dose) (Figure 3; panels A/B; both p<0.05).  In contrast, FBF and forearm 
vascular conductance in response to the endothelium-independent dilator sodium nitroprusside 
did not change across sodium conditions (Figure 3; panels C/D, p>0.80).  Results for all panels 
were similar when area under the curve was compared across sodium conditions (panels A/B, 
p<0.05; panels C/D, p>0.94).  FBF in the control arm did not change with sodium condition or 
drug infusions (not shown).  
 
Figure 3. 
 
Figure 3.  Forearm blood flow (panel A) and forearm vascular conductance (VC) (panel B) 
response to increasing doses of the endothelium-dependent dilator acetylcholine (ACh) (% 
increase vs. saline control) during the normal vs. low sodium condition; forearm blood flow 
(panel C) and forearm vascular conductance (VC) (panel D) response to increasing doses of the 
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endothelium-independent dilator sodium nitroprusside (SNP) (% increase vs. saline control) 
during the normal vs. low sodium condition.  Values are mean  S.E.; Bracketed * refers to the 
overall response across all doses; NS, normal sodium; LS, low sodium; * P<0.05 LS vs. NS; † 
P<0.01 LS vs. NS. 
 
The Improvement in EDD was Mediated by Increased NO Bioavailability.  Co-
infusion of the eNOS inhibitor L-NMMA reduced FBFACh (50% decrease at peak ACh dose) 
during the low sodium (Figure 4B; p<0.01) but not the normal sodium condition (Figure 4A; 
p=0.90), indicating increased NO bioavailability during the low sodium condition.  Results were 
similar when area under the curve was compared between the two conditions (panel A, p=0.98; 
panel B, p=0.07) and when EDD was expressed as forearm vascular conductance instead of 
FBFACh (not shown).  However, arterial endothelial cell protein expression of eNOS and PeNOS 
were unchanged across sodium conditions (Figures 4C and 4D; p>0.41). 
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Figure 4. 
            
Figure 4.  Forearm blood flow to increasing doses of acetylcholine (ACh) at baseline (gray line; 
ACh only) and during co-infusion of NG monomethyl-L-arginine (black line; L-NMMA) under the 
normal sodium (NS; panel A) and low sodium (LS; panel B) condition (% increase vs. saline 
control); arterial endothelial cell protein expression of endothelial nitric oxide synthase (eNOS; 
panel C) and eNOS phosphorylated at Ser 1177 (PeNOS; panel D) according to sodium 
condition (relative to human umbilical vein endothelial cell (HUVEC) control; representative 
images shown below).  Values are mean  S.E; bracketed comparison refers to the overall 
response across all doses; * P<0.01. 
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The Improvement in EDD was Mediated by Increased BH4 Bioavailability and 
Decreased Oxidative Stress.  FMDBA was improved with a systemic infusion of ascorbic acid 
during the normal sodium (46% increase) but not low sodium condition (Figure 5A; p<0.01 for 
repeated measures of saline vs. ascorbic acid).  Similarly, oral BH4 improved FMDBA under the 
normal sodium (66% increase) but not low sodium condition (Figure 5A; p<0.01 for repeated 
measures of saline vs. BH4), without altering SBP during either sodium condition (p>0.40).  
Improvements in FMDBA were similar when ascorbic acid and BH4 were co-administered (Figure 
5A; p<0.01 for repeated measures of saline vs. ascorbic acid + BH4).  These results persisted 
when covarying for SBP (p<0.01 for all three FMDBA comparisons above).  Endothelium-
independent dilation to NTG did not change with ascorbic acid + BH4 during either sodium 
condition (p>0.40; not shown).  Co-infusion of ascorbic acid also tended to improve FBFACh 
(50% increase at peak ACh dose) under the normal sodium (Figure 5B; p=0.05) but not low 
sodium condition (Figure 5C; p=0.20).  Results were similar when area under the curve was 
compared between the two conditions (panel B, p<0.01; panel C, p=0.60) and when EDD was 
expressed as forearm vascular conductance instead of FBFACh (not shown).  Brachial artery 
endothelial cell nitrotyrosine abundance, a marker of oxidative damage, tended to be reduced 
with low dietary sodium (Figure 5D; p=0.06). 
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Figure 5. 
              
 
Figure 5.  Brachial artery flow-mediated dilation (FMD, %∆) during the normal vs. low sodium 
condition according to co-administration of ascorbic acid (Vit C) and/or tetrahydrobiopterin (BH4) 
(panel A); forearm blood flow response to increasing doses of acetylcholine (ACh) at baseline 
(ACh only) and during co-infusion of ascorbic acid (Vit C) under the normal sodium (NS; panel 
B) and low sodium (LS; panel C) condition (% increase vs. saline control); arterial endothelial 
cell nitrotyrosine (NT) abundance according to sodium condition (relative to human umbilical 
vein endothelial cell (HUVEC) control; representative images shown below) (panel D).  Values 
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are mean  S.E; bracketed comparison refers to the overall response across all doses; * 
P<0.01. 
 
Discussion  
The findings of the present study are the first to show that restricting dietary sodium 
intake to a level consistent with the DASH diet and AHA recommendations improves EDD in 
middle-aged and older adults with moderately elevated SBP, whether assessed as FMDBA or 
FBFACh.  I have also provided the first insight in humans regarding the physiological 
mechanisms contributing to improvements in vascular endothelial function with dietary sodium 
restriction.  These results demonstrate that the mechanisms linking sodium to cardiovascular 
risk are likely far more complex than via blood pressure modulation alone, as dietary sodium 
restriction increased NO bioavailability, increased BH4 bioavailability and reduced oxidative 
stress. 
Dietary Sodium Restriction and Vascular Endothelial Function with 
Aging/Elevated SBP.   My results demonstrate that dietary sodium restriction improves EDD as 
assessed by FMDBA, a measure of peripheral conduit artery dilation to a mechanical (shear) 
stress, and FBFACh, an assessment of resistance vessel dilation in response to a chemical 
stimulus.  These findings are consistent with impairment in EDD to either a shear stress or 
chemical stimulus in animals (11, 12) and humans (39, 123) following a high sodium load.  The 
demonstrated benefits of dietary sodium restriction upon vascular function extend previous 
findings of reduced arterial stiffness (59, 114) and improved FMDBA (40) in select populations.  
Importantly, the magnitude of improvement in both FMDBA (71%) and peak FBFACh (53%) was 
quite large, similar to or greater than functional improvements we have found in our laboratory 
with aerobic exercise (FMDBA, 54% (100); peak FBF ACh, 30% (38)) and weight loss (FMDBA, 
30%;  peak FBF ACh, 26% (99)) interventions.  The improvements in vascular endothelial 
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function with dietary sodium restriction do not appear to have been mediated by changes in 
body composition, blood lipids, glucose, kidney function, physical activity, diet composition or 
circulating humoral factors, as these values did not change between sodium conditions.     
Dietary Sodium Restriction, EDD and Physiological Mechanisms.  I have 
demonstrated that the improvement in EDD with dietary sodium restriction is mediated by 
increased NO and BH4 bioavailability and reduced oxidative stress.  Importantly, the reduction in 
EDD with advancing age is mediated in part by decreased NO (44, 118) and BH4 (52, 66) 
bioavailability and increased oxidative stress (51, 118).  Thus, dietary sodium restriction may be 
an effective strategy to attenuate these age-related changes.  While this is the first available 
mechanistic insight into functional improvements in EDD with sodium restriction in humans, the 
results are consistent with findings in animals and non-intervention studies in humans.   
High salt feeding in rodents reduces NO bioavailability, which contributes to impaired 
EDD (11, 141).  In humans, salt loading acutely impairs EDD in young normotensive adults also 
by reducing NO bioavailability (123), and the impairment in EDD in salt-sensitive compared to 
salt-resistant adults with hypertension is associated with reductions in bioavailable NO (15, 77).  
In the present study, I have shown that low dietary sodium increases NO bioavailability without 
altering arterial eNOS expression.  Thus, it is reasonable to hypothesize that the demonstated 
improvements in BH4 bioavailability are contributing to the increase in NO.  Due to limitations in 
the delivery of BH4 (presently only available orally, thus cannot be used during assessment of 
FBFACh) and L-NMMA (can only be infused locally, or else systemic blood pressure would be 
altered), this concept could not be directly evaluated in the present work. 
The finding that sodium modulates BH4 bioavailability is novel, though consistent with a 
recent study in high salt fed mice (98).  High dietary sodium in rodents also impairs EDD by 
increasing oxidative stress, indicated by increased oxidative damage (7, 72), increased 
superoxide production (7, 97), reduced antioxidant activity (80) and improved EDD with the 
addition of an antioxidant (97).  In the present study, subjects no longer demonstrated functional 
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improvements in FMDBA and FBFACh with administration of ascorbic acid under the low sodium 
condition, indicating reduced oxidative stress compared to the normal sodium condition.  The 
lack of significant change in circulating markers of oxidative stress, in conjunction with a 
reduction in vascular endothelial cell nitrotyrosine abundance, support the concept that dietary 
sodium restriction reduces oxidative stress locally at the vascular endothelium.   
The reduction in SBP between sodium conditions, 12 mmHg, was very similar to our 
previous studies on dietary sodium restriction (59, 114).  In contrast to our previous work, I 
allowed inclusion of subjects on antihypertensive medications and still demonstrated similar 
reductions in SBP.  Importantly, the improvement in FMDBA remained significantly different 
between sodium conditions after statistically correcting for SBP, and the change in FMDBA was 
not correlated with the change in SBP.  Similarly, FBFACh was significantly improved during the 
low sodium condition when evaluated as the blood pressure corrected expression forearm 
vascular conductance.  Thus, dietary sodium restriction improved vascular endothelial function 
beyond its influence on SBP alone.   
The concept that high sodium has adverse cardiovascular effects independent of blood 
pressure has been advanced in recent years by animal and human literature.  High dietary 
sodium has been repeatedly shown to impair EDD even in rodents that are salt resistant, thus 
do not exhibit increases in blood pressure in response to a high sodium diet (11, 80, 84, 98).  
Acute impairment of FMDBA in normotensive adults following a high salt load is also blood 
pressure independent (39), and adults with elevated SBP who report lower sodium intake have 
enhanced FMDBA independent of blood presssure (69).  The present findings lend support to an 
overall hypothesis advanced by Frolich (56) that salt loading not only elevates arterial blood 
pressure, but also contributes to adverse functional alterations to target organs.  Thus, sodium 
restriction may help reverse age-associated alterations in vascular function, beyond its benefit 
of blood pressure lowering.   
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Limitations.  Due to complexity of the study design, including multiple measures of 
vascular function and pharmacodissection of contributing physiological mechanisms, there was 
a relatively small number of study participants.  Thus, results may not be extrapolated to all 
individuals and future work should explore the efficacy of dietary sodium restriction for improving 
vascular function in other populations.  While the interaction between gender/medication use 
and responsiveness to dietary sodium restriction was intruiging, the study was not powered to 
perform sub-group analyses.  Future work should follow-up on the significant interaction term 
found between these factors and sodium condition.  
Conclusions.   The results of the present study support the hypothesis that dietary 
sodium restriction to a level consistent with the DASH diet and AHA recommendations improves 
vascular endothelial function, as assessed by FMDBA or FBFACh.  A low sodium diet improves 
EDD via mechanisms independent of/in addition to reductions in SBP, including an increase in 
NO and BH4 bioavailability and reduction in oxidative stress.  
Perspectives.  Dietary sodium intake in modern societies such as the United States 
greatly exceeds current recommendations (4, 124).  Sodium restriction improves reverses 
vascular endothelial dysfunction, and the physiological mechanisms modulating this 
improvement are beyond blood pressure lowering alone.  Thus, the potential impact of lowering 
dietary sodium upon risk of CVD may be even greater than previously appreciated.  These 
findings lend support to the American Heart Association’s recent call to action for a population-
wide effort to reduce sodium consumption (4).     
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CHAPTER VI 
 
Conclusions 
 
I used two different approaches to examine the modulation of vascular endothelial 
function by dietary sodium intake in middle-aged and older adults with moderately elevated 
systolic blood pressure (SBP).  First, I found that lower self-reported sodium intake is associated 
with enhanced endothelium-dependent dilation (EDD), as assessed by brachial artery flow-
mediated dilation (FMDBA).  Second, I used a randomized, placebo-controlled cross-over 
intervention to demonstrate that dietary sodium restriction improves EDD, as assessed by both 
FMDBA and the forearm blood flow response to acetylcholine (FBFACh).  I also showed that 
enhancements in nitric oxide (NO) and tetrahydrobiopterin (BH4) bioavailability and reductions in 
oxidative stress mediated the improvements in EDD with a low sodium diet.  NO bioavailability 
was increased with dietary sodium restriction, as co-infusion the endothelial nitric oxide 
synthase (eNOS) inhibitor NG-monomethyl-L-arginine (L-NMMA) reduced FBFACh when subjects 
were undergoing the low sodium, but not normal sodium condition.  Consistent with aging 
studies, subjects demonstrated improvements in EDD with acute administration of BH4 and 
ascorbic acid while on the normal sodium diet.  However, BH4 and/or ascorbic acid no longer 
improved EDD during the low sodium condition, indicating that reduced oxidative stress and 
increased BH4 bioavailability contributed to the improvement in EDD.  Oxidative damage, as 
measured by endothelial cell nitrotyrosine abundance, was also reduced with the low sodium 
diet.  The functional improvements in EDD were independent of reductions in SBP.    
In summary, dietary sodium restriction improves EDD in middle-aged and older adults 
with moderately elevated SBP.  The physiological mechanisms mediating reductions in vascular 
dysfunction are independent of/in addition to reductions in SBP, including increased NO and 
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BH4 bioavailability and decreased oxidative stress.  Thus, the potential impact of lowering 
dietary sodium upon risk of cardiovascular diseases may be even greater than previously 
appreciated.  As dietary sodium intake in modern societies such as the United States greatly 
exceeds current recommendations, these findings lend support to the American Heart 
Association’s recent call to action for a population-wide effort to reduce dietary sodium 
consumption.  
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